Kryptos Biotechnologies

PCR is one of those technologies that is simultaneously miraculous and annoying. Miraculous because it can take a single strand of DNA and copy it billions of times, which is how you find out whether the thing in your nose is a virus. Annoying because the standard way to do it involves heating and cooling a sample over and over with a metal block, and metal blocks - this is the deep insight - are not in a hurry. The result is that the most important diagnostic tool of the last forty years mostly lives in a lab, and you wait.

Kryptos Biotechnologies, founded in 2017 and headquartered in Hayward, California, looked at this arrangement and made a somewhat contrarian decision: keep the chemistry, throw out the heating block. In its place the company put light. The core technology is called photothermal heating, and it works by shining light onto an optical thin film that converts photons into precisely controlled heat. There is no contact, the heating is localized, and - crucially - it is fast. Fast enough that the company's Ultrafast Photonic PCR engine completes 40 thermal cycles in under 10 minutes while, the company says, holding the same sensitivity as a conventional machine.

Now, "we made the heating part faster" does not sound like a company. It sounds like a component. The trick of building an actual business here is that a diagnostic is a system, and the PCR run is only one part of it. Before you can amplify DNA you have to extract it from a messy biological sample; after you amplify it you have to read the result. Kryptos wrapped all of that into a product called Kuick - a sample-to-answer system that pairs the photonic PCR with solid-phase sample extraction inside a low-cost disposable cartridge, and hands back a result in roughly 20 minutes. The idea is that the machine could sit in a clinic, an urgent care, or a point-of-care setting rather than a reference lab, which is another way of saying the test comes to the patient instead of the other way around.

The company's stated mission is agreeably plain: to give clinicians and scientists systems that "reveal the complexity of biology to help them make the right decisions on time." That last phrase - on time - is doing quiet work. A test that is 99% accurate and arrives two days late has, in a lot of clinical situations, the informational value of a horoscope. Speed is not a vanity metric in diagnostics; it is frequently the whole point.

There is a name joke here worth noting. Kryptos is Greek for hidden, which is a slightly cheeky choice for a company whose entire proposition is revealing what is hidden inside a biological sample. The logo, fittingly, is a slash - the mark you make when you cut something. In this case the thing being cut is time.

Whether this works at scale is, at the moment, an open and expensive question, which is the honest thing to say about any pre-commercial diagnostics company. Kuick is not yet a product you can buy; it is a product in clinical studies chasing FDA clearance, with an early focus on respiratory infections and, via a grant-funded project, sexually transmitted infections. That is the part of the story that has not been written. What has been written is the physics and the check.